Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Research output: Contribution to journalReviewResearchpeer-review

  1. Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T1 -weighted perfusion MRI

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparison of global cerebral blood flow measured by phase-contrast mapping MRI with (15) O-H2 O positron emission tomography

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prospective frequency correction for macromolecule-suppressed GABA editing at 3T

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

Original languageEnglish
JournalJournal of Magnetic Resonance Imaging
Volume25
Issue number6
Pages (from-to)269-274
Number of pages6
ISSN1053-1807
DOIs
Publication statusPublished - Dec 2016

    Research areas

  • Chelating Agents, Contrast Media, Drug Hypersensitivity, Evidence-Based Medicine, Gadolinium, Humans, Hypersensitivity, Immediate, Magnetic Resonance Imaging, Treatment Outcome, Journal Article, Review

ID: 52653295